Umb Bank, N.A. Plus Therapeutics, Inc. Transaction History

Umb Bank, N.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 13, 2022	BUY	$0.48 - $7.5 $3 - $60	8 Added 17.39%	54 $0
Q1 2022 Apr 22, 2022	BUY	$0.87 - $1.32 $10 - $15	12 Added 35.29%	46 $0
Q4 2021 Feb 09, 2022	BUY	$1.03 - $1.94 $35 - $65	34 New	34 $0

Ticker PSTV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,601,400
Market Cap $46.4M
Description
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

Stay updated on Umb Bank, N.A. with notifications on news.